Becton, Dickinson & Co (NYSE:BDX) on 01/25/2022 declared a dividend of $ 0.8700 per share payable on March 31, 2022 to shareholders of record as of March 10, 2022.
Becton, Dickinson & Co (NYSE:BDX) has paid dividends since 1926, has a current dividend yield of 1.3386675119% and has increased its dividends for 10 successive years.
Becton, Dickinson & Co's market cap is $ 73,834,879,040 and has a PE ratio of 37.95. The stock price closed yesterday at $ 259.96 and has a 52 week low/high of $ 235.13 and $ 268.55.
Becton, Dickinson and Company is a medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. Co.'s business segments are: BD Medical, which produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings; BD Life Sciences, which provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers; and BD Interventional, which provides vascular, urology, oncology and surgical products.
For more information on Becton, Dickinson & Co click here.
Becton, Dickinson & Co current dividend information as per the date of this press release is: